We are live on ! Find out more
AssetMark Inc

AssetMark Inc Portfolio holdings

AUM $58.2B
1-Year Est. Return 22.78%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+22.78%
3 Year Est. Return
+68.16%
5 Year Est. Return
+68.87%
10 Year Est. Return
+184.44%
AUM
$27.7B
AUM Growth
+$2.66B
Cap. Flow
+$289M
Cap. Flow %
1.04%
Top 10 Hldgs %
29.52%
Holding
2,033
New
292
Increased
959
Reduced
465
Closed
198
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLTO icon
601
Veralto
VLTO
$23B
$1.38M 0.01%
+16,792
New +$1.25M
KMB icon
602
Kimberly-Clark
KMB
$36.3B
$1.37M 0.01%
11,297
+1,640
+17% +$198K
KRTX
603
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.37M 0.01%
4,332
+1,164
+37% +$226K
FOLD
604
DELISTED
Amicus Therapeutics
FOLD
$1.36M ﹤0.01%
95,743
+25,082
+35% +$285K
COR icon
605
Cencora
COR
$60.6B
$1.36M ﹤0.01%
6,602
+288
+5% +$56.2K
CGDG icon
606
Capital Group Dividend Growers ETF
CGDG
$5.43B
$1.35M ﹤0.01%
+49,864
New +$1.28M
BWXT icon
607
BWX Technologies
BWXT
$15.5B
$1.34M ﹤0.01%
17,517
+4,961
+40% +$381K
SLQD icon
608
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.37B
$1.34M ﹤0.01%
27,204
-1,249
-4% -$60.4K
VRSK icon
609
Verisk Analytics
VRSK
$25.4B
$1.33M ﹤0.01%
5,566
+494
+10% +$117K
BUFT icon
610
FT Vest Buffered Allocation Defensive ETF
BUFT
$155M
$1.33M ﹤0.01%
63,783
+22,516
+55% +$454K
COKE icon
611
Coca-Cola Consolidated
COKE
$12.5B
$1.33M ﹤0.01%
14,290
+70
+0.5% +$5.07K
ALNY icon
612
Alnylam Pharmaceuticals
ALNY
$27.5B
$1.32M ﹤0.01%
6,913
+1,135
+20% +$193K
FTV icon
613
Fortive
FTV
$17.9B
$1.32M ﹤0.01%
23,792
+9,037
+61% +$477K
SPG icon
614
Simon Property Group
SPG
$74.4B
$1.32M ﹤0.01%
9,252
-1,161
-11% -$140K
PSA icon
615
Public Storage
PSA
$60.5B
$1.32M ﹤0.01%
4,321
+419
+11% +$111K
ICE icon
616
Intercontinental Exchange
ICE
$85.6B
$1.31M ﹤0.01%
10,224
+86
+0.8% +$9.75K
SO icon
617
Southern Company
SO
$109B
$1.31M ﹤0.01%
18,705
+3,367
+22% +$231K
VWO icon
618
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$1.31M ﹤0.01%
31,844
+6,437
+25% +$255K
SXI icon
619
Standex International
SXI
$3.59B
$1.31M ﹤0.01%
8,256
+271
+3% +$39K
BIIB icon
620
Biogen
BIIB
$30B
$1.3M ﹤0.01%
5,035
+161
+3% +$39.5K
TKR icon
621
Timken Company
TKR
$9.56B
$1.29M ﹤0.01%
16,129
+1
+0% +$74
WST icon
622
West Pharmaceutical
WST
$24B
$1.29M ﹤0.01%
3,650
+1,050
+40% +$372K
POST icon
623
Post Holdings
POST
$4.14B
$1.28M ﹤0.01%
14,565
+452
+3% +$38.4K
IT icon
624
Gartner
IT
$10.1B
$1.27M ﹤0.01%
2,813
-619
-18% -$247K
NDSN icon
625
Nordson
NDSN
$16.6B
$1.26M ﹤0.01%
4,779
+1,286
+37% +$298K

Similar funds

AssetMark Inc's Q4 2023 Portfolio in Review

As of Q4 2023, AssetMark Inc held 2,033 positions worth $27.7B, up 11% from $25B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

AssetMark Inc's Q4 2023 filing shows 292 new, 959 increased, 465 reduced and 198 closed positions. Its largest new stake was Invesco Variable Rate Investment Grade ETF: 1,903,702 shares worth $47.6M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $393M.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7% a quarter earlier, followed by Healthcare and Financials.

  • AssetMark Inc's largest Q4 2023 buy was Invesco Variable Rate Investment Grade ETF: 1,903,702 shares worth $47.6M.
  • AssetMark Inc added most to iShares 20+ Year Treasury Bond ETF in Q4 2023, an estimated $396M increase.
  • AssetMark Inc's biggest Q4 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $393M.
  • AssetMark Inc fully exited Schwab Intermediately-Term US Treasury ETF in Q4 2023, selling an estimated $30.7M.
  • AssetMark Inc's ten largest holdings make up 30% of its $27.7B portfolio in Q4 2023.
  • AssetMark Inc opened 292 new positions and closed 198 in Q4 2023.
  • AssetMark Inc's portfolio value rose 11% quarter-over-quarter to $27.7B.

Based on AssetMark Inc's 13F filing for Q4 2023, filed 9 Feb 2024.